Darya Chudova - 01 Dec 2023 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role: Chief Technology Officer
Signature: /s/ John G. Saia, as attorney-in-fact for Darya Chudova
Issuer symbol: GH
Transactions as of: 01 Dec 2023
Net transactions value: -$2,870
Form type: 4
Filing time: 04 Dec 2023, 18:24:06 UTC
Previous filing: 16 Nov 2023
Next filing: 15 Dec 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GH	COMMON STOCK	Options Exercise	$0	+315	+1.1%	$0.000000	27,998	01 Dec 2023	Direct
transaction	GH	COMMON STOCK	Tax liability	$2,870	-109	-0.39%	$26.33	27,889	01 Dec 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GH	RESTRICTED STOCK UNITS	Options Exercise	$0	-315	-12%	$0.000000	2,210	01 Dec 2023	COMMON STOCK	315	$0.000000	Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
F2	The restricted stock unit award was granted on November 2, 2021, of which 3,157 shares are outstanding on May 3, 2023, when elected as an executive officer. These shares vest in equal quarterly installments on the anniversary of 9/1/2022, and fully vested on 9/1/2025.
F3	Not applicable for Restricted Stock Units.